Agios Andreas Hospital is a hospital in Patras, Achaea, Greece. It is the second largest hospital in the city of Patras and one of the largest in Peloponnese with a total capacity of 400 beds. The hospital occupies 5 buildings of which the 3 are situated close to each other.

There are 400 beds in General Hospital of Patras Agios Andreas.

During the past decade, General Hospital of Patras Agios Andreas conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital of Patras Agios Andreas" #1 sponsor was "Amgen" with 2 trials, followed by "Hellenic Cooperative Oncology Group" with 2 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Karyopharm Therapeutics Inc" with 1 trials sponsored and "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital of Patras Agios Andreas" #1 collaborator was "Belgium and Luxembourg Gynaecological Oncology Group" with 1 trials as a collaborator, "Care Across Ltd" with 1 trials as a collaborator, "Israel Society of Gynecologic Oncology" with 1 trials as a collaborator, "Merck Hellas sa., Greece, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital of Patras Agios Andreas" are "Breast Cancer" (1 trials), "Endometrial Cancer" (1 trials), "Multiple Myeloma" (1 trials), "Multiple Sclerosis" (1 trials) and "Non-Small Cell Carcinoma of Lung, TNM Stage 4" (1 trials). Many other conditions were trialed in "General Hospital of Patras Agios Andreas" in a lesser frequency.

Most popular intervention types in "General Hospital of Patras Agios Andreas" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (1 trials), "Cabazitaxel" (1 trials), "Carfilzomib" (1 trials), "Cladribine" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital of Patras Agios Andreas" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "General Hospital of Patras Agios Andreas". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in General Hospital of Patras Agios Andreas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital of Patras Agios Andreas, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".